Filed: 4/1/2026ACC: 0002081668-26-000003
📋 What this filing means
ROYALTY PHARMA SUB-MANAGER, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $171.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$171.31M
Total AUM (reported)
9.03M
Total Shares
Allocation by class
COM$171.31M100.0%
Portfolio Concentration
Top 3$141.31M82.5%
4–10$30.00M17.5%
Top 3 weight
82.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.03M
Sole
Full voting authority
9.03M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
CYTOKINETICS, INC
DFNDShares980.39K
TypeSH
Market value$62.29M
36.36%
Sole
980.39K
Shared
0.00
None
0.00
ZENAS BIOPHARMA, INC.
DFNDShares1.26M
TypeSH
Market value$45.86M
26.77%
Sole
1.26M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares2.94M
TypeSH
Market value$33.15M
19.35%
Sole
2.94M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
DFNDShares3.85M
TypeSH
Market value$30.00M
17.51%
Sole
3.85M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS, INCDFND | COM | 980.39K | SH | $62.29M 36.36% | 980.39K | 0.00 | 0.00 |
ZENAS BIOPHARMA, INC.DFND | COM | 1.26M | SH | $45.86M 26.77% | 1.26M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 2.94M | SH | $33.15M 19.35% | 2.94M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCDFND | COM | 3.85M | SH | $30.00M 17.51% | 3.85M | 0.00 | 0.00 |